Friess Associates’s Cerence CRNC Stock Holding History

Friess Associates’s Portfolio CRNC Stock Details CRNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-23,457	Closed	-$1.15M	–	104
2020 Q3	$1.15M	Buy	+23,457	New	+$1.13M	0.1%	96

Other funds holding CRNC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VVP

Vulcan Value Partners Birmingham, Alabama $3.77B AUM 9.63% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Isomer Partners New York $74.3M AUM 23.95% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return

Friess Associates's CRNC Position: Q4 2020 in Review

Friess Associates sold out of Cerence (CRNC) in Q4 2020, closing a stake of 23,457 shares — an estimated $1.15M sold.

Friess Associates first reported a position in CRNC in Q3 2020 and held it in 1 quarter. The position peaked at $1.15M in Q3 2020. 326 funds tracked by Wall St. Rank hold CRNC as of Q4 2020.

Friess Associates reported no remaining Cerence position as of Q4 2020 after selling out during the quarter.
Friess Associates sold 23,457 Cerence shares in Q4 2020, an estimated $1.15M.
Friess Associates first reported a position in Cerence in Q3 2020 and held it in 1 quarter.
Friess Associates's Cerence position peaked at $1.15M in Q3 2020.
326 funds tracked by Wall St. Rank held Cerence as of Q4 2020.

Based on Friess Associates's 13F filing for Q4 2020, filed 12 Feb 2021.